Renewable Energy Production Slows down due to Lack of Transformers
Boston Scientific Entered into an Agreement to Acquire Apollo Endosurgery, Inc.
By Rahul Gotadki , 06 December, 2022
Boston Scientific revealed to enter into a definitive agreement to acquire Apollo Endosurgery, Inc. by paying USD 10 per share in cash, signifying the company's valuation to be around USD 615 million. The recent De Novo clearance from FDA for treating bariatric and other procedures and extensive product pipeline for the endoscopy segment pursued Boston Scientific to add Apollo Endosurgery's commodity to their product portfolio. The company's acquisition is aimed at strengthening the endoscopy bariatric business of Boston Scientific.
The emerging demand for endoluminal surgery (ELS) and the high success rate of the endoscopy procedure created intent for the acquisition of Apollo Endosurgery. Also, Boston Scientific planned to expand its expertise in the ELS domain using Apollo Endosurgery's unique, innovative measures. Moreover, the acquisition enabled the organization to expand its expertise in a new adjacent market (endobariatric industry) and is anticipated to deliver robust and prolonged market growth in the projected period.
The growth in Apollo Endosurgery's endoscopic suturing system franchise comprises the X-Tack Endoscopic HeliX Tracking System, OverStitch Sx Endoscopic Suturing System, and OverStitch Endoscopic Suturing System. They are likely to record net sales of nearly USD 76 million by the end of the year (2022). Therefore, these aspects strengthen the business outlook and create a favorable trade environment for Boston Scientific.
A major factor expected to benefit Boston Scientific is the De Novo clearance of Apollo Endosurgery's Apollo ESG and Apollo Revise series systems. These FDA-authorized devices will be used to conduct endoscopic bariatric revision and endoscopic sleeve gastroplasty procedures. The approval of the systems is likely to support the organization's sales and help the company hold a significant share of the bariatric surgery market. Moreover, Boston Scientific anticipates settling the payment in the first two quarters of 2023 while looking at future economic and demographic trends and regulatory conditions.Average Weight Loss-Gastric Sleeve, RNY Gastric Bypass, Lap Band to Sleeve
Latest News
Renewable Energy Production Slows down due to Lack of Transformers
Renewables are in high demand in the energy market in 2024. It is due to a clean energy transition that requires a constant flow of renewables in the energy market. The green transformation to combat climate change brings about several environmental…
Packaging Manufacturer Collabs with Solar Projects to Enhance Cleantech in 2024
Companies are making significant moves towards the clean energy transition in various ways. In order to reduce carbon emissions, certain companies are investing in several rescue methods in 2024. Renewables production is growing over time as the…
Amazon Enables News Technologies to Help its Business Customers
Amazon is one of the leading global e-commerce platforms for consumers. The brand boosts its online shopping experience for users in multiple ways. Surveys show that Amazon regulates several business solutions to increase its products and services…
Asian Carbon Emissions Affects West’s Clean Energy Transition Process in 2024
Globally, countries are facing challenges in the transformation of green energy. The economies worldwide target to achieve net zero emissions. Hence, countries are introducing several ways to reduce environmental carbon emissions. Developing…
China to Boost Oil and Gas Production from New Sources in 2024
China is the leading nation in the energy market. Since the clean energy transition focuses on renewables, China surpasses other nations in renewables production. In a mission to strengthen its energy security, China moves forward with oil and gas…
Rahul Gotadki
Assistant Manager
